| Jun 26 |
Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
|
| Jun 26 |
Biggest stock movers today: RIVN, FDX, TSHA
|
| Jun 26 |
Taysha Gene Therapies stock slides after commence securities offering to raise $75 million
|
| Jun 25 |
Taysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
|
| Jun 20 |
Taysha Gene Therapies: Latest Rett Data Checks Momentum, Road Ahead Rocky
|
| Jun 18 |
Taysha falls after data for Rett syndrome candidate
|
| Jun 18 |
Taysha Gene Therapies Announces Positive Clinical Data Across Adult and Pediatric Patients from Low Dose Cohort in Ongoing REVEAL Phase 1/2 Trials Evaluating TSHA-102 in Rett Syndrome
|
| Jun 18 |
Sanofi taps Belharra for immune drug research; AstraZeneca’s new cancer drug falls short
|
| Jun 13 |
How to Invest in Penny Stocks in 2024: 3 Best Picks
|
| Jun 12 |
Taysha Gene Therapies to Present Clinical Data from Both REVEAL Phase 1/2 Trials During Company-Hosted Webcast and at 2024 IRSF Rett Syndrome Scientific Meeting
|
